Amgen to host investor webcast at ESMO 2026 Congress
Biopharmaceutical company Amgen has scheduled an investor call for October 24, 2026, coinciding with the European Society for Medical Oncology Congress.
Amgen will host a webcast call for the investment community on October 24, 2026, at 11:30 a.m. PT. The event is timed to coincide with the European Society for Medical Oncology (ESMO) 2026 Congress, where the company plans to share clinical updates.
Murdo Gordon, executive vice president of global commercial operations, is scheduled to lead the discussion. The session will focus on the company's oncology pipeline and the clinical data being presented to the medical community during the event.
The presentation is intended to provide analysts and shareholders with context regarding the company’s recent research findings and their potential impact on the clinical oncology market. Further information on how to access the live audio webcast is available through Amgen's investor relations portal.